Prothena to Present New Preclinical Data for NEOD001 at 57th Annual American Society of Hematology Meeting
November 05, 2015 09:20 ET
|
Prothena Corporation plc
DUBLIN, Ireland, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization...